drug developers

Digital

Health Technology Assessment – Challenges and opportunities ...

Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster

R&D

Partner Content

3rd World ADC Asia

Optimising Physiochemical, Potency & Impurity Analytical Methods to Ensure Regulatory Compliance

R&D

Partner Content

CRISPR-Based Therapy Analytical Development Summit

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.

Health Technology Assessment – Challenges and opportunities ...

3rd World ADC Asia

CRISPR-Based Therapy Analytical Development Summit

Spyre deprioritises arthritis drug after Phase 2 results

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks